glp-1 drugs and multiple sclerosis Emerging research suggests that medications like Ozempic Wegovy might be beneficial for people with MS. Researchers are exploring how maintaining a healthy weight impacts MS symptoms and how like GLP-1s and Multiple Sclerosis -

A 2026 analysis of 25 products found zero contained semaglutide

A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a persons risk of other health conditions.

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Learn why people explore it and what to consider before trying it.

After a few years of injectable dominance, oral formulations are emerging as a game-changer for adherence and ease of use thanks to their lack of cold-chain requirement, but also a game-changer for their ability to unlock the long-term maintenance opportunity [14]

As California ends Medicaid coverage for GLP-1 weight loss drugs likeWegovy and Zepbound, experts say the states advice to simply eat better isnt realistic for many patients.